HEPATITIS MEDICINES WERE VERY EXPENSIVE. ALL PATIENTS WERE NOT ABLE TO AFFORD THE SAME. NOW ALL PATENTS GIVEN BY USA COMPANY TO INDIAN PHARMACEUTICALS COMPANIES AND MANUFACTURE HERE IN INDIA.
ALMOST ALL HEPATITIS MEDICINES AVAILABLE IN INDIA NOW.
Lancer health care launched langra 100 tablets. For the use of men.
Velpanat, a sofosbuvir-velpatasvir fixed dose combination, is generic version of Gilead''s Epclusa. Natco Pharma Limited has launched Velpanat – a fixed dose combination medicine containing sofosbuvir (400 mg) velpatasvir (100 mg) – for the treatment of hepatitis C.